3rd Annual Atlanta Precision Oncology Symposium
Video Player is loading.
10 seconds
Playback speed
ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Govitecan Improve PFS? Should We Use Tala vs. Chemo for BRCA1/2 Patients? Is Olaparib Mono a New SoC?
Comments 0
Login to view comments.
Click here to Login
